BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05232071-completion@plaintrial.com
DTSTAMP:20261028T142252Z
DTSTART;VALUE=DATE:20240604
SUMMARY:Placebo-controlled\, Proof-of-concept Study to Evaluate the Safety 
 and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor
  EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus — esti
 mated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT05232071
URL:https://plaintrial.com/trial/NCT05232071
END:VEVENT
END:VCALENDAR